tadalafil has been researched along with indomethacin in 5 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (indomethacin) | Trials (indomethacin) | Recent Studies (post-2010) (indomethacin) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 29,527 | 1,838 | 3,396 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Christiansen, ML; Hagner Nielsen, L; Müllertz, A; Plum, J; Rades, T; Stie, MB; Strindberg, S | 1 |
Abd Al Haleem, EN; Arafa, HMM; Ibrahim, FAM; Zaytoon, SAB | 1 |
Abo-Saif, AA; Alghamdi, BS; Elkomy, MH; Mohamed, WR; Mohamed, YT; Naguib, IA | 1 |
1 review(s) available for tadalafil and indomethacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for tadalafil and indomethacin
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of supersaturation on absorption of indomethacin and tadalafil in a single pass intestinal perfusion rat model, in the absence and presence of a precipitation inhibitor.
Topics: Administration, Oral; Animals; Chemical Precipitation; Excipients; Hypromellose Derivatives; Indomethacin; Intestinal Absorption; Intestine, Small; Male; Models, Animal; Perfusion; Permeability; Rats; Rats, Sprague-Dawley; Solubility; Solvents; Tadalafil | 2020 |
Possible protective effect of TNF-α inhibition and triad NO/cGMP/VEGF activation on gastric ulcer in rats.
Topics: Animals; Cyclic GMP; Dinoprostone; Indomethacin; Male; Malondialdehyde; Nitric Oxide; Pentoxifylline; Rats; Stomach Ulcer; Tadalafil; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2021 |
Role of ADMA/DDAH-1 and iNOS/eNOS signaling in the gastroprotective effect of tadalafil against indomethacin-induced gastric injury.
Topics: Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Indomethacin; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostaglandins E; Quality of Life; Rats; Stomach Ulcer; Tadalafil; Ulcer | 2022 |